Details:

Alternative Title:
In the absence of SARS-CoV transmission worldwide : guidance for surveillance, clinical and laboratory evaluation, and reporting;Guidance for surveillance, clinical and laboratory evaluation, and reporting;
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)
Description:
Severe acute respiratory syndrome (SARS) came to global attention in February 2003, when officials in China informed the World Health Organization (WHO) about 305 cases of atypical pneumonia that had occurred in Guangdong Province. By the time the new infectious disease was declared contained in July 2003, more than 8,000 cases and 780 deaths had been reported from 29 countries worldwide. Since then, active global surveillance for SARS-associated coronavirus (SARS-CoV) disease in humans has detected no laboratory-confirmed person-to-person transmission of SARS-CoV. No one knows if, when, or where person-to-person transmission of SARS-CoV will recur. However, the rapidity of spread of infection and the high levels of morbidity and mortality associated with SARS-CoV call for careful monitoring for the recurrence of transmission and preparations for the rapid implementation of control measures. The 2003 global outbreaks demonstrated the ease with which SARS-CoV can seed and spread in human populations when cases remain undetected or when infected persons are not cared for in controlled environments that reduce the risk of transmission to others. The two laboratory-acquired infections and the recent cases in Southern China show that SARS-CoV continues to be a threat. Early detection of SARS cases and contacts, plus swift and decisive implementation of containment measures, are therefore essential to prevent transmission. Although the United States had only a limited SARS-CoV outbreak during the 2003 epidemic -- with only eight laboratory-confirmed cases and no significant local spread -- the U.S. population is clearly vulnerable to the more widespread, disruptive outbreaks experienced in other countries. During this period of no known person-to-person transmission of SARS- CoV in the world, healthcare and public health officials must therefore do what they can to prepare for the possibility that SARS-CoV transmission may recur. This document provides guidance for surveillance, clinical and laboratory evaluation, and reporting in the setting of no known person-to-person transmission of SARS-CoV worldwide. Recommendations are derived from Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS) www.cdc.gov/ncidod/sars/guidance/index.htm. If such transmission recurs anywhere in the world, CDC will promptly review all available information and provide additional guidance via the Health Alert Network (HAN), Epi-X, and partner organizations. Current information will also be posted on CDC's SARS website: www.cdc.gov/sars.
Content Notes:
January 21, 2004.

This is an updated version of a document first issued by CDC in December 2003. The document provides guidance for surveillance, clinical and laboratory evaluation, and reporting in the setting of no known person-to-person transmission of SARS-CoV worldwide. Recommendations are derived from Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS).

Mode of access: Internet from the CDC web site as Acrobat .pdf file (461 KB, 15 p. ).


Subjects:
[+]
Communicable Disease Control/methods Disease Notification Public Health Surveillance Severe Acute Respiratory Syndrome/diagnosis Severe Acute Respiratory Syndrome/prevention & Control
Document Type:
Pamphlet (or booklet)
Genre:
Guideline
Collection(s):
Stephen B. Thacker CDC Library collection
Main Document Checksum:
[+]
urn:sha256:dde979874559f2e7ccbfcb3c59bd92e96ab96300f7ee18eea497cab4230f561f
Download URL:
https://stacks.cdc.gov/view/cdc/13534/cdc_13534_DS1.pdf
File Type:

Supporting Files

• No Additional Files

More +